{"id":41029,"date":"2025-08-01T01:00:46","date_gmt":"2025-08-01T05:00:46","guid":{"rendered":"https:\/\/www.ncqa.org\/?page_id=41029"},"modified":"2026-01-30T07:58:56","modified_gmt":"2026-01-30T12:58:56","slug":"metabolic-monitoring-for-children-and-adolescents-on-antipsychotics-apm-e","status":"publish","type":"page","link":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/metabolic-monitoring-for-children-and-adolescents-on-antipsychotics-apm-e\/","title":{"rendered":"Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E)"},"content":{"rendered":"<p><span data-contrast=\"auto\">The percentage of persons 1\u201317 years of age who had two or more antipsychotic prescriptions and had metabolic testing. Three rates are reported:<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<ul>\n<li><span data-contrast=\"auto\">The percentage of persons on antipsychotics who received blood glucose testing.<\/span><\/li>\n<li><span data-contrast=\"auto\">The percentage of persons on antipsychotics who received cholesterol testing.<\/span><\/li>\n<li><span data-contrast=\"auto\">The percentage of persons on antipsychotics who received blood glucose and cholesterol testing.<\/span><\/li>\n<\/ul>\n<h2>Why It Matters?<\/h2>\n<p><span data-contrast=\"none\">Antipsychotic medications offer the potential for effective treatment of psychiatric disorders in children; however, they can also increase a child\u2019s risk for developing serious health concerns, including metabolic health complications. Antipsychotic medications are associated with several potentially adverse impacts, including weight gain and diabetes <sup><a href=\"#ref-1\">1<\/a><\/sup> <sup><a href=\"#ref-2\">2<\/a><\/sup> <sup><a href=\"#ref-3\">3<\/a><\/sup>.<\/span><\/p>\n<p><span data-contrast=\"none\">A multi-year study of youth enrolled in three HMOs found that exposure to atypical antipsychotics was associated with a fourfold risk of diabetes in the following year, compared to children not prescribed a psychotropic medication, the broader class of medications under which antipsychotics fall <sup><a href=\"#ref-3\">3<\/a><\/sup>. Another study of youth enrolled in a state Medicaid plan found that those starting an antipsychotic had three times the risk of developing diabetes, compared to youth starting other psychotropic medications. The association of atypical antipsychotics with diabetes has been found to be greater among children and adolescents than among adults <sup><a href=\"#ref-4\">4<\/a><\/sup> <sup><a href=\"#ref-5\">5<\/a><\/sup>.<\/span><\/p>\n<p><span data-contrast=\"none\">Research suggests that metabolic problems in childhood and adolescence are associated with poor cardiometabolic outcomes in adulthood <sup><a href=\"#ref-6\">6<\/a><\/sup>. The long-term consequences of pediatric obesity and other metabolic disturbances include higher risk of heart disease in adulthood <sup><a href=\"#ref-7\">7<\/a><\/sup>. Due to the potential negative health consequences associated with children developing cardiometabolic side effects from an antipsychotic medication, it is important to both establish a baseline and continuously monitor metabolic indices to ensure appropriate management of side-effects.<\/span><\/p>\n<p><span data-contrast=\"none\">The American Academy of Child and Adolescent Psychiatry guidelines recommend metabolic monitoring, including monitoring of glucose and cholesterol levels, for children and adolescents on antipsychotic medications <sup><a href=\"#ref-8\">8<\/a><\/sup>.<\/span><\/p>\n<p><span data-contrast=\"none\"><i>Developed with financial support from the Agency for Healthcare Research and Quality (AHRQ) and the Centers for Medicare &amp; Medicaid Services (CMS) under CHIPRA Pediatric Quality Measures Program Centers of Excellence grant number U18HS020503.<\/i><\/span><\/p>\n<h2>Historical Results \u2013 National Averages<\/h2>\n","protected":false},"excerpt":{"rendered":"<p>The percentage of persons 1\u201317 years of age who had two or more antipsychotic prescriptions and had metabolic testing. Three rates are reported:\u00a0 The percentage of persons on antipsychotics who received blood glucose testing. The percentage of persons on antipsychotics who received cholesterol testing. The percentage of persons on antipsychotics who received blood glucose and [&hellip;]<\/p>\n","protected":false},"author":45,"featured_media":0,"parent":733,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page.php","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-41029","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) - NCQA<\/title>\n<meta name=\"description\" content=\"Assesses children who turned 15 months old during the measurement year and had 0\u20136 well-child visits with a primary care physician during their first 15 months of life.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/metabolic-monitoring-for-children-and-adolescents-on-antipsychotics-apm-e\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) - NCQA\" \/>\n<meta property=\"og:description\" content=\"Assesses children who turned 15 months old during the measurement year and had 0\u20136 well-child visits with a primary care physician during their first 15 months of life.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/metabolic-monitoring-for-children-and-adolescents-on-antipsychotics-apm-e\/\" \/>\n<meta property=\"og:site_name\" content=\"NCQA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/NCQA.org\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-30T12:58:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ncqa.org\/wp-content\/uploads\/2021\/04\/NCQA_cmyk_tag.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@NCQA\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/metabolic-monitoring-for-children-and-adolescents-on-antipsychotics-apm-e\/\",\"url\":\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/metabolic-monitoring-for-children-and-adolescents-on-antipsychotics-apm-e\/\",\"name\":\"Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) - NCQA\",\"isPartOf\":{\"@id\":\"https:\/\/www.ncqa.org\/#website\"},\"datePublished\":\"2025-08-01T05:00:46+00:00\",\"dateModified\":\"2026-01-30T12:58:56+00:00\",\"description\":\"Assesses children who turned 15 months old during the measurement year and had 0\u20136 well-child visits with a primary care physician during their first 15 months of life.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/metabolic-monitoring-for-children-and-adolescents-on-antipsychotics-apm-e\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/metabolic-monitoring-for-children-and-adolescents-on-antipsychotics-apm-e\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/metabolic-monitoring-for-children-and-adolescents-on-antipsychotics-apm-e\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ncqa.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Report Cards\",\"item\":\"https:\/\/www.ncqa.org\/report-cards\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Health Plans\",\"item\":\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"State of Health Care Quality Report\",\"item\":\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/\"},{\"@type\":\"ListItem\",\"position\":5,\"name\":\"Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ncqa.org\/#website\",\"url\":\"https:\/\/www.ncqa.org\/\",\"name\":\"NCQA\",\"description\":\"Measuring quality. Improving health care.\",\"publisher\":{\"@id\":\"https:\/\/www.ncqa.org\/#organization\"},\"alternateName\":\"National Committee for Quality Assurance\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ncqa.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ncqa.org\/#organization\",\"name\":\"NCQA\",\"alternateName\":\"National Committee for Quality Assurance\",\"url\":\"https:\/\/www.ncqa.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ncqa.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ncqa.org\/wp-content\/uploads\/NCQA-Blog-Logo-Thumbnail.jpg\",\"contentUrl\":\"https:\/\/www.ncqa.org\/wp-content\/uploads\/NCQA-Blog-Logo-Thumbnail.jpg\",\"width\":876,\"height\":673,\"caption\":\"NCQA\"},\"image\":{\"@id\":\"https:\/\/www.ncqa.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/NCQA.org\",\"https:\/\/x.com\/NCQA\",\"https:\/\/www.instagram.com\/ncqa_dc\/\",\"https:\/\/www.youtube.com\/@NcqaOrg\",\"https:\/\/www.linkedin.com\/company\/ncqa\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) - NCQA","description":"Assesses children who turned 15 months old during the measurement year and had 0\u20136 well-child visits with a primary care physician during their first 15 months of life.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/metabolic-monitoring-for-children-and-adolescents-on-antipsychotics-apm-e\/","og_locale":"en_US","og_type":"article","og_title":"Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) - NCQA","og_description":"Assesses children who turned 15 months old during the measurement year and had 0\u20136 well-child visits with a primary care physician during their first 15 months of life.","og_url":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/metabolic-monitoring-for-children-and-adolescents-on-antipsychotics-apm-e\/","og_site_name":"NCQA","article_publisher":"https:\/\/www.facebook.com\/NCQA.org","article_modified_time":"2026-01-30T12:58:56+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/www.ncqa.org\/wp-content\/uploads\/2021\/04\/NCQA_cmyk_tag.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@NCQA","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/metabolic-monitoring-for-children-and-adolescents-on-antipsychotics-apm-e\/","url":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/metabolic-monitoring-for-children-and-adolescents-on-antipsychotics-apm-e\/","name":"Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) - NCQA","isPartOf":{"@id":"https:\/\/www.ncqa.org\/#website"},"datePublished":"2025-08-01T05:00:46+00:00","dateModified":"2026-01-30T12:58:56+00:00","description":"Assesses children who turned 15 months old during the measurement year and had 0\u20136 well-child visits with a primary care physician during their first 15 months of life.","breadcrumb":{"@id":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/metabolic-monitoring-for-children-and-adolescents-on-antipsychotics-apm-e\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/metabolic-monitoring-for-children-and-adolescents-on-antipsychotics-apm-e\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/metabolic-monitoring-for-children-and-adolescents-on-antipsychotics-apm-e\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ncqa.org\/"},{"@type":"ListItem","position":2,"name":"Report Cards","item":"https:\/\/www.ncqa.org\/report-cards\/"},{"@type":"ListItem","position":3,"name":"Health Plans","item":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/"},{"@type":"ListItem","position":4,"name":"State of Health Care Quality Report","item":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/"},{"@type":"ListItem","position":5,"name":"Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E)"}]},{"@type":"WebSite","@id":"https:\/\/www.ncqa.org\/#website","url":"https:\/\/www.ncqa.org\/","name":"NCQA","description":"Measuring quality. Improving health care.","publisher":{"@id":"https:\/\/www.ncqa.org\/#organization"},"alternateName":"National Committee for Quality Assurance","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ncqa.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ncqa.org\/#organization","name":"NCQA","alternateName":"National Committee for Quality Assurance","url":"https:\/\/www.ncqa.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ncqa.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.ncqa.org\/wp-content\/uploads\/NCQA-Blog-Logo-Thumbnail.jpg","contentUrl":"https:\/\/www.ncqa.org\/wp-content\/uploads\/NCQA-Blog-Logo-Thumbnail.jpg","width":876,"height":673,"caption":"NCQA"},"image":{"@id":"https:\/\/www.ncqa.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/NCQA.org","https:\/\/x.com\/NCQA","https:\/\/www.instagram.com\/ncqa_dc\/","https:\/\/www.youtube.com\/@NcqaOrg","https:\/\/www.linkedin.com\/company\/ncqa\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/pages\/41029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/users\/45"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/comments?post=41029"}],"version-history":[{"count":1,"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/pages\/41029\/revisions"}],"predecessor-version":[{"id":49507,"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/pages\/41029\/revisions\/49507"}],"up":[{"embeddable":true,"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/pages\/733"}],"wp:attachment":[{"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/media?parent=41029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}